Trials / Completed
CompletedNCT02690025
A Phase 2 Trial Testing ZP1848 in Patients With SBS
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 18 (actual)
- Sponsor
- Zealand Pharma · Industry
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
A proof-of-concept, dose finding, controlled, single-center, randomized, double-blind, fixed dose phase 2 trial with ZP1848 in patients with Short Bowel Syndrome.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ZP1848 |
Timeline
- Start date
- 2016-02-01
- Primary completion
- 2017-05-01
- Completion
- 2017-05-01
- First posted
- 2016-02-24
- Last updated
- 2017-06-21
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02690025. Inclusion in this directory is not an endorsement.